Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
ConditionOpioid Use Disorder
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Minnesota
About this trial
The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).
Eligibility criteria
Qualifiers
Ability to provide consent and comply with study procedures
Diagnostic and Statistical Manual of Mental Disorders criteria for OUD
Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD
Intention to remain in the study until intervention completion.
Disqualifiers
Any medical condition with neurological sequelae
Head injury resulting in skull fracture or loss of consciousness of >30 minutes
Any tDCS or MRI contraindication (tDCS: history of seizures, metallic cranial plates/screws or implanted device, history of eczema on scalp. MRI: unapproved metallic implants, pacemakers or any other implanted electrical device, shrapnel, metallic braces, non-removable body piercings, pregnancy, breathing or movement disorder, or claustrophobia)
Any psychotic disorder (participants with other treated and stable psychiatric disorders will be included)
Trial design
Treatments tested in this trial
- Transcranial Direct Current Stimulation (tDCS)
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov